This screening study also documented an issue regarding theseresearch methods that is not related to Fabry disease - the occurrence of a mutation ofunknown significance in GLA gene, and showed the clinical management required to definethe role of the mutation on the development of the clinical presentation. This evidence concerns the gene GLA and Fabry disease.